$GLUE 4 SEC Filings

Filed On	Filing
06 Oct 2026	Form 4: Bowen Matthew, Principal Accounting Officer Sold 13 shares ($137)
17 Jul 2026	Form 4: Warmuth Markus, Director Sold 9,500 shares ($220K)
16 Jul 2026	Form 4: Champoux Jennifer, Chief Operating Officer Received 4,351 shares by exercise or conversion ($17.3K) · Sold 4,351 shares ($102K)
07 Jul 2026	Form 4: Townson Sharon, Chief Scientific Officer Received 6,000 shares by exercise or conversion ($36.8K) · Sold 6,000 shares ($140K)
06 Jul 2026	Form 4: Behbahani Ali, Director Disposed of 1,015,000 shares (Other Transaction) · Acquired 15,000 shares (Other Transaction)
01 Jul 2026	Form 4: Janku Filip, Chief Medical Officer Received 5,407 shares by exercise or conversion ($72.5K) · Sold 5,407 shares ($132K)
30 Jun 2026	Form 4: Janku Filip, Chief Medical Officer Received 6,000 shares by exercise or conversion ($45.4K) · Sold 6,000 shares ($138K)
30 Jun 2026	Form 4: Manning Anthony M., Director Received 10,000 shares by exercise or conversion ($41.6K) · Sold 10,000 shares ($231K)
25 Jun 2026	Form 4: Janku Filip, Chief Medical Officer Received 6,000 shares by exercise or conversion ($45.4K) · Sold 11,845 shares ($240K) · Received 30,000 shares by exercise or conversion ($227K) · 1 more
25 Jun 2026	Form 4: Champoux Jennifer, Chief Operating Officer Received 2,175 shares by exercise or conversion ($8.66K) · Sold 2,175 shares ($43.5K)
25 Jun 2026	Form 4: Townson Sharon, Chief Scientific Officer Received 3,000 shares by exercise or conversion ($18.4K) · Sold 3,000 shares ($60K)
18 Jun 2026	Form 4: Champoux Jennifer, Chief Operating Officer Received 2,176 shares by exercise or conversion ($8.66K) · Sold 2,176 shares ($41.3K)
18 Jun 2026	Form 4: Townson Sharon, Chief Scientific Officer Received 3,000 shares by exercise or conversion ($18.4K) · Sold 3,000 shares ($57K)
12 Jun 2026	Form 4: Behbahani Ali, Director Granted 25,800 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Schiff Andrew N, Director Granted 25,800 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Manning Anthony M., Director Granted 25,800 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Skvarka Jan, Director Granted 25,800 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Blackwell Kimberly, Director Granted 25,800 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Hughes Eric A, Director Granted 25,800 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Siu Christine, Director Granted 25,800 Stock Option (Right to Buy)

Comments